Prognosis of secondary acute myeloid leukemia

Leukemia Research

Volumn 37, Issue 8, 2013, Pages 857-858

  Della Porta, Matteo Giovanni ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT; DAUNORUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER PATIENT; CANCER SURVIVAL; CHEMOSENSITIVITY; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DRUG MEGADOSE; EDITORIAL; FAMILIAL CANCER; GENETIC DISORDER; GENOTYPE; HAPLOINSUFFICIENCY; HEMATOPOIESIS; HUMAN; INDUCTION CHEMOTHERAPY; LEUKEMIA REMISSION; MALIGNANT TRANSFORMATION; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SECONDARY ACUTE MYELOID LEUKEMIA; SOMATIC MUTATION; SURVIVAL TIME;

ACUTE DISEASE; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; LEUKEMIA, MYELOID; MUTATION; MYELODYSPLASTIC SYNDROMES; ONCOGENES; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 84879779947     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.04.016     Document Type: Editorial

References (7)

1. Malcovati L., Della Porta M.G., Cazzola M. Predicting survival and leukemic evolution in patients with myelodysplastic syndrome. Haematologica 2006, 91:1588-1590.
2. Okuyama N., Sperrb W.R., Kadarc K., Bakkerd S., Szombathc G., Handae H., et al. Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: a multicenter retrospective study. Leuk Res 2013, 37:862-867.
3. Alessandrino E.P., Della Porta M.G., Bacigalupo A., Van Lint M.T., Falda M., Onida F., et al. WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Blood 2008, 112:895-902.
4. Malcovati L., Papaemmanuil E., Bowen D.T., Boultwood J., Della Porta M.G., Pascutto C., et al. Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Blood 2011, 118:6239-6246.
5. Walter M.J., Shen D., Ding L., Shao J., Koboldt D.C., Chen K., et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med 2012, 366:1090-1098.
6. Bejar R., Stevenson K., Abdel-Wahab O., Galili N., Nilsson B., Garcia-Manero G., et al. Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med 2011, 364:2496-2506.
7. Patel J.P., Gönen M., Figueroa M.E., Fernandez H., Sun Z., Racevskis J., et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 2012, 366:1079-1089.